Empagliflozin Clinical Trials
19 recruitingDrug
Phase 27Phase 36Phase 44Phase 12Early Phase 11
Showing 1–19 of 19 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled413 locationsNCT06531824
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1151 locationsNCT07064473
Recruiting
Phase 3
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting
Phase 2
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Chronic Kidney Disease
Boehringer Ingelheim416 enrolled153 locationsNCT06926660
Recruiting
Phase 1Phase 2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Metastatic Breast Cancer
Hoffmann-La Roche792 enrolled45 locationsNCT03424005
Recruiting
Phase 2
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Diabetes
Mostafa Bahaa105 enrolled1 locationNCT06762314
Recruiting
Phase 3
Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Tanta University40 enrolled1 locationNCT05669742
Recruiting
Phase 4
Randomized Trial of SGLT2i in Heart Transplant Recipients
Heart TransplantCardiovascular DiseaseKidney Disease
VA Office of Research and Development200 enrolled6 locationsNCT06625073
Recruiting
Phase 4
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Type II Diabetes MellitusEfficacy, SelfSafety Issues
Getz Pharma2,000 enrolled6 locationsNCT05164263
Recruiting
Phase 1
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
Healthy SubjectsOverweight Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.111 enrolled1 locationNCT07331389
Recruiting
Phase 2
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
Major Depressive Disorder
NYU Langone Health16 enrolled1 locationNCT05757791
Recruiting
Phase 2
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
ObesityVascular Health
VA Office of Research and Development50 enrolled1 locationNCT06745063
Recruiting
Phase 2
Feasibility Trial for a Right Ventricular Failure Platform Trial
Pulmonary HypertensionRight Ventricular DysfunctionRight Heart Failure
University of Alberta30 enrolled5 locationsNCT06570473
Recruiting
Phase 2
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease
Cantonal Hospital Graubuenden40 enrolled2 locationsNCT06435858
Recruiting
Early Phase 1
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
Ulcerative Colitis
Tanta University60 enrolled1 locationNCT05610956
Recruiting
Phase 4
Empagliflozin Treatment in Kidney Transplant Recipients
Kidney TransplantChronic Kidney Disease
VA Office of Research and Development264 enrolled5 locationsNCT06013865
Recruiting
Phase 3
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
Heart Failure
Colorado Prevention Center1,500 enrolled15 locationsNCT06024746
Recruiting
Phase 4
Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Type 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre46 enrolled1 locationNCT06021145
Recruiting
Phase 3
Randomised Evaluation of COVID-19 Therapy
Severe Acute Respiratory Syndrome
University of Oxford70,000 enrolled7 locationsNCT04381936